Low-grade chondrosarcoma of bone: experiences from the Vienna Bone and Soft Tissue Tumour Registry.
In a retrospective single-centre study, 70 low-grade chondrosarcoma (LCS) (31 female/39 male patients with a mean age of 40 years) were reviewed to evaluate surgical management. The mean overall follow-up was 81 months (median: 73 months, range: 6-317 months). Seventeen lesions (24.3%) in the trunk and 53 (75.7%) in the extremities were treated by curettage (48.6%) or resection (51.5%). Local recurrence occurred in eight patients (11.4%) 18 months postoperatively (median: 18 months, range: 0-41 months). Recurrence-free survival was significantly better for patients with extremity lesions compared to truncal lesions, but was not affected by resection margin. The anatomical site "trunk" and an "intralesional" resection margin had a significant independent prognostic influence in multivariate analysis. Curettage with local adjuvants is a viable treatment option for most extremity LCS. In truncal LCS wide resection is recommended despite a potentially higher complication rate.
Funovics
Philipp T
PT
Medical University of Vienna Department of Orthopaedic Surgery, Vienna General Hospital, Waehringer Guertel 18-20, 1090, Vienna, Austria. philipp.funovics@meduniwien.ac.at
Panotopoulos
Joannis
J
Sabeti-Aschraf
Manuel
M
Abdolvahab
Farshid
F
Funovics
Josef M
JM
Lang
Susanna
S
Kotz
Rainer I
RI
Dominkus
Martin
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D001317:Austria / Q000453:epidemiology; D001859:Bone Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D002648:Child; D002813:Chondrosarcoma / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D011183:Postoperative Complications; D012042:Registries; D012189:Retrospective Studies; D015996:Survival Rate; D055815:Young Adult
Clin Orthop Relat Res. 1980 Nov-Dec;(153):106-20
7449206
Clinics (Sao Paulo). 2005 Apr;60(2):121-6
15880247
J Bone Joint Surg Am. 1999 Mar;81(3):326-38
10199270
J Bone Joint Surg Br. 2005 Nov;87(11):1527-30
16260673
Clin Orthop Relat Res. 2010 Feb;468(2):581-9
19727994
Cancer. 2001 Apr 1;91(7):1201-12
11283918
Clin Orthop Relat Res. 2009 Aug;467(8):2105-11
19142690
Acta Orthop Scand. 1995 Jun;66(3):283-8
7604716
Clin Orthop Relat Res. 2001 Oct;(391):224-33
11603673
Eur J Surg Oncol. 2009 Dec;35(12):1343-7
19570648
Cancer. 1996 Apr 1;77(7):1292-7
8608505
Clin Orthop Relat Res. 2007 Sep;462:175-80
17514007
Cancer. 1982 Aug 1;50(3):577-83
7093898
J Cancer Res Clin Oncol. 2009 Apr;135(4):543-50
18855011
J Bone Joint Surg Br. 2002 Jan;84(1):93-9
11837841
J Bone Joint Surg Am. 1956 Oct;38-A(5):1025-38; passim
13367080
Cancer. 1996 Aug 15;78(4):745-50
8756367
J Bone Joint Surg Br. 1979 Nov;61-B(4):395-400
500746
Clin Orthop Relat Res. 2007 Oct;463:166-72
17632422
Clin Orthop Relat Res. 2006 Oct;451:201-7
16788412
Radiology. 1984 Jan;150(1):21-6
6689763
Med Sci Monit. 2009 Mar;15(3):CS44-8
19247248
Clin Orthop Relat Res. 1980 Nov-Dec;(153):44-66
7449231
Cancer. 1998 Nov 15;83(10):2105-19
9827715